• Mashup Score: 0

    Nutritional epidemiology seeks to understand nutritional determinants of disease in human populations using experimental and observational study designs. Though randomized controlled trials provide the strongest evidence of causality, the expense and difficulty of sustaining adherence to dietary interventions are substantial barriers to investigating dietary determinants of kidney disease. Therefore, nutritional epidemiology commonly employs observational study designs, particularly prospective cohort studies, to investigate long-term associations between dietary exposures and kidney disease.

    Tweet Tweets with this article
    • Review by Valerie K. Sullivan and Casey M. Rebholz: Nutritional Epidemiology and Dietary Assessment for Patients With Kidney Disease: A Primer https://t.co/YZFN4tawMn (FREE) @JHUWelchCenter @JohnsHopkinsEPI #kidneydisease https://t.co/E9vyhdZVOj

  • Mashup Score: 0

    “A doctor, like a writer, must have a voice of his own, something that conveys the timbre, the rhythm, the diction, and the music of his humanity, that compensates us for all the speechless machine…

    Tweet Tweets with this article
    • CALL FOR SUBMISSIONS: How has #kidneydisease impacted your life? Consider sharing your experience to our "In A Few Words" feature. We welcome submissions from patients/physicians/allied health professionals/family members. Details on the #AJKDBlog: https://t.co/fvCfyiBqIf https://t.co/9mhvV9etr1

  • Mashup Score: 2

    Ahead of the sotagliflozin approval, Deepak Bhatt, MD, MPH, offers perspective into potential future research opportunities for the SGLT1/2 inhibitor and discusses the impact of a 3rd agent boasting SGLT2 inhibition receiving approval for heart failure.

    Tweet Tweets with this article
    • Based on SOLOIST-WHF and SCORED, previously presented at the @AHAMeetings and published in the @NEJM, #sotagliflozin has been approved by the @US_FDA. #cardiotwitter #cardiology #heartfailure #kidneydisease #diabetes @gabrielsteg @cpcannon https://t.co/AOj5DG8Mak via @hcplive